腫瘤靶向oHA-VES納米聚合物膠束載體的構(gòu)建與評價
[Abstract]:Aim to synthesize and characterize amphiphilic block polymer oligomeric polyhyaluronic acid-vitamin E succinate (oHAVES),) to prepare mixed polymer micelles containing docetaxel (oHA-VES/F68) and investigate their physicochemical properties and evaluate HAVES/F68-DTX in vitro and in vivo. Methods Amphiphilic block polymer carrier material was synthesized by the reaction of hyaluronic acid (oHA) with vitamin E succinate (VES). OHA-VES/F68 mixed polymer micelles were prepared by ultrasonic method. The morphology, particle size and Zeta potential, entrapment efficiency, drug loading and in vitro release of oHA-VES/F68 were investigated. The critical micelle concentration (CMC).) of the polymer was investigated by pyrene fluorescence probe method. The morphology, particle size and Zeta potential of polymer micelles were characterized by transmission electron microscope (TEM),) Ma Erwen dynamic light scattering particle size analyzer and dialyzed method. The synthesis of oHA-VES was identified by IR (FTIR) and 1H NMR. The cytotoxicity of MCF-7 cells was investigated by MTT assay. The fluorescence intensity of polymer micelles in mice after 24 hours was measured by in vivo imaging technique using DiR dye as fluorescence probe. Results oHA-VES polymer carrier materials were synthesized by amidation reaction, and oHAVES/F68 mixed polymer micelles were prepared by ultrasonic method. The particle size potential, encapsulation efficiency and drug loading of oHA-VES/F68-DTX were (91.2 鹵7.51) nm, (-10.4 鹵0.47) mV, (80.36 鹵1.54) and (2.69 鹵0.26), respectively. Under transmission electron microscope, the particles of oHA-VES/F68-DTX were spherical and round in shape. The cumulative release rate of DTX for 72 h was determined by 80.74%.CCK-8 method. The IC50 value of DTX to MCF-7 cells was 9.7 渭 g mL-1,oHA-VES/F68-DTX. There was no cytotoxicity in the blank carrier of DTX HA-VES. In vivo imaging showed that the polymer micelles of OHA-VES / F68 could significantly improve the targeting of polymer micelles in vivo. Conclusion the oHA-VES/F68-DTX polymer micelles were successfully prepared by ultrasonic method, and the preparation method is simple and feasible. The particle size and encapsulation efficiency of oHA-VES/F68-DTX with certain slow release properties were better. In vitro cell experiments showed that OHA-VES / F68-DTX had obvious cytotoxicity to cells. In vivo experiments showed that the oHA-VES / F68-DTX polymer micelles were highly targeted. OHA-VES was an effective carrier for the delivery of DTX to tumor cells.
【學(xué)位授予單位】:佳木斯大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R943
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 畢學(xué)玲;劉建波;張海波;;混合膠束在口服遞藥系統(tǒng)的研究進(jìn)展[J];藥物生物技術(shù);2016年01期
2 盛竹君;徐維平;徐婷娟;金勤玉;吳亞東;楊東梅;;納米技術(shù)在難溶性藥物制劑研究中的應(yīng)用[J];廣州化工;2016年01期
3 陳萬青;鄭榮壽;;中國女性乳腺癌發(fā)病死亡和生存狀況[J];中國腫瘤臨床;2015年13期
4 王天琪;張娜;;透明質(zhì)酸在腫瘤治療中的應(yīng)用[J];生命的化學(xué);2014年05期
5 李揚(yáng)龔;沈園園;錢嫦云;陸菲;徐曉芬;;混合膠束作為藥物載體的研究進(jìn)展[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2014年19期
6 龐鑫;翟光喜;;維生素E聚乙二醇1000琥珀酸酯在藥物制劑中的應(yīng)用[J];中國新藥與臨床雜志;2014年04期
7 張庭;周建平;姚靜;;阿霉素聚合物膠束的制備及其體外特性評價[J];中國藥科大學(xué)學(xué)報;2013年05期
8 吳道澄;顧雪凡;;透明質(zhì)酸載體靶向治療消化系腫瘤的研究進(jìn)展[J];世界華人消化雜志;2012年32期
9 劉雯;李娟;;泊洛沙姆混合膠束的研究進(jìn)展[J];亞太傳統(tǒng)醫(yī)藥;2012年08期
10 孫李平;王曉宇;朱全剛;高申;;透明質(zhì)酸納米給藥載體的研究進(jìn)展[J];藥學(xué)服務(wù)與研究;2012年04期
,本文編號:2231431
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2231431.html